期刊文献+

清肝泄浊法治疗脂肪肝30例临床研究 被引量:2

Purging the liver fire and clearing the liver for fatty liver:clinical study of 30 cases
原文传递
导出
摘要 目的:观察清肝泄浊法治疗脂肪肝的临床疗效。方法:治疗组30例口服自拟清肝泄浊汤,对照组24例口服复方益肝灵,观察肝功能及血脂变化。结果:治疗组30例,有效率90.0%,对照组30例,有效率36.6%。结论:清肝泄浊法治疗脂肪肝的疗效明显,适宜临床推广运用。 Objective:To observe the effect of purging the liver fire and clearing the liver for fatty liver.Methods:In treatment group,30 patients were given decoction of purging the liver fire and clearing the liver for fatty liver;in control group,24 cases were given Compound Yiganling.Liver function and serum lipid were observed.Results:The effective rate of treatment group was 90.0%;36.6%,in the control group.Conclusion:Purging the liver fire and clearing the liver for fatty liver has obvious effect,which is suitable for clinical application.
出处 《现代生物医学进展》 CAS 2010年第17期3268-3270,共3页 Progress in Modern Biomedicine
关键词 脂肪肝 清肝泄浊法 湿浊 fatty liver purging the liver fire and clearing the liver dampness
作者简介 于洁(1973-),女,副主任医师,硕士学历,主要研究方向:消化道肿瘤
  • 相关文献

参考文献7

二级参考文献83

共引文献1711

同被引文献28

  • 1Early Breast Cancer Trialists ' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomised trials [ J ]. Lancet, 2005,365 (9472) : 1687-1717.
  • 2Nishino M, Hayakawa K, Nakamura Y, et al. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy [ J ]. Am J Roentgenol, 2003,180( 1 ) :129-134.
  • 3Kotiloglu G, Aki ZS, Ozyilkan O, et al. Tamoxifen-induced cirrhotic process [ J ]. Breast J,2001,7 (6) :442-443.
  • 4Hewitt KN, Pratis K, Jones ME, et al. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse [ J ]. Endocrinology, 2004,145 : 1842-1848.
  • 5Egawa T, Toda K, Nemoto Y, et al. Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (At-/-) mice[J]. Lipids,2003,38(5) :519-523.
  • 6Lelliott C J, Lopez M, Curtis RK, et al. Transcript and metabolite analysis of the effects of tamoxifen in liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis [ J ]. FASEB J, 2005,19 ( 9 ) : 1108-1119.
  • 7Larosche I, Letteron P, Fromenty B, et al. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver [ J]. J Pharmacol Exp Ther,2007,321 ( 1 ) :526-535.
  • 8Zhao F, Xie P, Jiang JL, et al. The effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitro [ J]. Int J Mol Sci,2014,15(3) :4019-4030.
  • 9Oddrun AG,Therese HR, Rolf KB. Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver[ J ]. J Lipids Res ,2006,47 (10) :2223-2232.
  • 10Taishi M, Yasuyuki T, Koichi T, et al. Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models [ J ]. J Toxicol Sci, 2012, 37(5) :931-942.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部